Skip to main content
. Author manuscript; available in PMC: 2024 Apr 30.
Published in final edited form as: Annu Rev Microbiol. 2018 Sep 8;72:423–446. doi: 10.1146/annurev-micro-090817-062414

Figure 1.

Figure 1

Vaccine approaches with complete and partial efficacy in nonhuman primate models. Successful single platforms in a prime or prime-boost approach are pictured on the left, whereas combined platforms in a prime-boost approach are depicted on the right. Abbreviations: Ad, adenovirus; CMV, cytomegalovirus; EBOVΔVP30, Ebola virus lacking the gene for VP30; HPIV3, human parainfluenza virus type 3; MVA, modified vaccinia virus Ankara; RABV, rabies virus; VEEV, Venezuelan equine encephalitis virus; VLP, Ebola virus–like particles; VSV, vesicular stomatitis virus.